Borja Ibáñez
Borja Ibáñez is the scientific director of the National Center for Cardiovascular Research (CNIC) and an interventional cardiologist at the Hospital Fundación Jiménez Díaz. He is recognized for his work in cardiovascular research and healthcare.
Not in the pool (under ¢1).
Recent news mentions
Borja Ibáñez is a key author of the study that challenges the necessity of beta-blockers for certain heart patients.
Un macroestudio confirma que millones de personas toman un fármaco contra el infarto sin necesitarlo: “Vamos a ahorrar millones de euros” | Ciencia
Spain· 2025-11-09
Borja Ibáñez is the scientific director at the National Center for Cardiovascular Research in Madrid and co-author of the study discussing the ineffectiveness of beta-blockers.
Un medicament comun pentru inimă, luat de milioane de oameni, ar putea crește riscul de deces
Romania· 2025-09-04
Borja Ibáñez is the principal investigator of the REBOOT trial and a cardiologist at the Hospital Universitario Fundación Jiménez Díaz.
Estudio revela que tras un infarto mujeres tienen peor pronóstico cuando usan betabloqueantes
Dominican Republic· 2025-08-31Borja Ibáñez is a cardiologist leading a study that reveals beta-blockers are ineffective for most patients post-heart attack.
Betabloqueantes: Más de un millón de personas en España toman cada día un tratamiento contra el infarto que no sirve para nada | CienciaSpain· 2025-08-30
Borja Ibáñez is the lead study author and scientific director for Madrid’s National Center for Cardiovascular Investigation.
Some women have higher risk of death on common heart attack medication, study finds
United States· 2025-08-30
Borja Ibáñez is the scientific director of the National Center for Cardiovascular Research.
España, ante el reto de mantenerse a la cabeza mundial en ensayos clínicos | SociedadSpain· 2025-02-21
